SECURE CLOUD ACCESS

IF THERE IS NO EARLY DIAGNOSIS,
THEN THERE IS NO TIMELY TREATMEN

AUTONOMIC NERVOUS SYSTEM
​AND VASCULAR ASSESSMENTS

LD PRODUCTS:  EARLY DETECTION OF DIABETES COMPLICATIONS
AUTONOMIC NERVOUS SYSTEM AND VASCULAR FUNCTION ASSESSMENTS
blood pressure and arterial stiffness analysis

BLOOD PRESSURE AND ARTERIAL STIFFNESS ANALYSIS


Monitoring and treatment.
Management of hypertension, 
heart rate variability, HVR

HEART RATE VARIABILITY (HRV)

Cardiac Autonomic Dysfunction Assessment.
Cardiac Autonomic reflex tests, HVR
photoplethysmography

PHOTOPLETHYSMOGRAPHY

Mathematical Analysis of the
​pulse Ox   wave. 

CARDIAC AUTONOMIC REFLEX TESTs (CARTs)

Cardiac Autonomic Neuropathy Assessment.
Ankle Brachial Index, ABI
Sudomotor function tests

SUDOMOTOR
FUNCTION TESTS

ANKLE BRAKIAL INDEX (ABI)


Peripheral Artery Disease (PAD).
Blood flow blockage or calcification.
CMicrocirculation and
​small fiber Assessments

MAIN SYMPTOMS OF AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION ​​

FATIGUE
HEADACHE
DIZZINESS
EXERCISE INTOLERANCE
FAINTING
TINGLING IN THE TOES OR FINGERS
CLAUDICATION
PAINFUL MUSCLE CRAMPING IN THE HIPS, THIGHS OR CALVES WHEN WALKING, CLIMBING STAIRS OR EXERCING.
   

USA POPULATION THAT SHOULD BE TESTED BY LD TECHNOLOGY PRODUCTS

AUTONOMIC NEUROPATHY AND VASCULAR DYSFUNCTION IN THE USA.

50+
Population over 50 years old
with cardiovascular risk factors
(Hypertensive, Overweight, Smoker, Diabetic).

70+
Population over 70 years old.

OVER 45 MILLIONS PEOPLE
EVERYONE IN THE RISK GROUP SHOULD BE MEASURED WITH LD PRODUCTS
NEW INTERFACES : THE PAD SERIES

                ADAPTED TO THE HEALTH PROFESSIONAL NEEDS 
DOWNLOAD LD PRODUCTS CATALOG